Your browser doesn't support javascript.
loading
Development of a novel near-infrared fluorescent theranostic combretastain A-4 analogue, YK-5-252, to target triple negative breast cancer.
Kong, Yali; Smith, Jacqueline; Li, Kongwen; Cui, Jake; Han, John; Hou, Shujie; Brown, Milton L.
Afiliação
  • Kong Y; Drug Discovery & Development, Inova Schar Cancer Institute; Drug Discovery Center, Inova Center for Personalized Health, 3225 Gallows Rd, Fairfax, VA 22031, United States.
  • Smith J; Department of Natural Sciences, Bowie State University, 14000 Jericho Park Dr, Crawford 207A, Bowie, MD 20716, United States.
  • Li K; Fairfax High School, 3501 Rebel Run, Fairfax, VA 22030, United States.
  • Cui J; Thomas Jefferson High School for Science and Technology, 6560 Braddock Road, Alexandria 22312, United States.
  • Han J; James Madison High School, 2500 James Madison Drive, Vienna, VA 22181, United States.
  • Hou S; Department of Oncology, Center for Drug Discovery, Georgetown University Medical Center, 3970 Reservoir Rd, Washington D.C. 20057, United States.
  • Brown ML; Drug Discovery & Development, Inova Schar Cancer Institute; Drug Discovery Center, Inova Center for Personalized Health, 3225 Gallows Rd, Fairfax, VA 22031, United States. Electronic address: Milton.Brown@inova.org.
Bioorg Med Chem ; 25(7): 2226-2233, 2017 04 01.
Article em En | MEDLINE | ID: mdl-28284864
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Estilbenos / Benzopiranos / Neoplasias de Mama Triplo Negativas / Nanomedicina Teranóstica Limite: Humans Idioma: En Ano de publicação: 2017 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Estilbenos / Benzopiranos / Neoplasias de Mama Triplo Negativas / Nanomedicina Teranóstica Limite: Humans Idioma: En Ano de publicação: 2017 Tipo de documento: Article